HCA Healthcare, Inc. (HCA) earnings on April 24, 2026

After the market closes Q1 2026

More HCA Healthcare, Inc. earnings

Prior outlook: No statistical edge

HCA's stock saw a solid gain after its earnings, closing up 3.08%. This positive movement happened even though there were signs of slowing momentum beforehand.

HCA price around the earnings

445.77

Change: +3.1%

2026-04-27, 20:00 UTC

Start of the measured window End of the measured window
425.39 443.25 461.12 478.98 432.56
Price series around the eventClosing price per minute from before the event to the end of the measured window.No trading (market closed)
April 24, 2026 April 27, 2026
  • Price: green if it ends above the starting price; red if it ends below
  • Start of the measured window
  • End of the measured window
  • Market open
  • No trading (market closed)
  • Starting price
Price series around the event

Prior thesis

Prior outlook: No statistical edge

Thesis published

Positive outlook tempered by weakening price trend.

Analysts have set price targets significantly higher than the current stock price, and the company has a history of meeting or exceeding expectations. However, recent price movements suggest a weakening trend, which is a point of caution.

Context analyzed before publication

Summary
Strong analyst upside and a strong recent record of beating earnings, but severe negative momentum divergence.
Reasoning
Strong analyst upside and a strong recent record of beating earnings, but severe negative momentum divergence.

Analysts

Evidence

Analyst consensus
Buy
Consensus average (1-5)
1.96
Analysts covering the stock
21
Average price target
542.67
Lowest price target
425
Highest price target
635
Upside to price target
15.1%
Quarterly earnings growth
30.6%
Revenue growth
6.7%
Forward EPS
33.33
Trailing EPS
28.33
Analyst moves in the last 60 days
3
  • Strong buy: 2
  • Buy: 13
  • Hold: 9
  • Sell: 1
  • Strong sell: 0
Strong buy
2
Buy
13
Hold
9
Sell
1
Strong sell
0
  • March 10, 2026 · TD Cowen: Maintains rating (Buy → Buy)
  • February 25, 2026 · Mizuho: Maintains rating (Outperform → Outperform)
  • February 23, 2026 · UBS: Maintains rating (Buy → Buy)

News and sentiment

Evidence

Sentiment
Sentiment
Constructive
Mention volume
Low
Normalized volume
33%
News

There is no news coverage available for this event.

Technicals

Evidence

Average true range (ATR)
2.5%
Distance to 52-week high
-15.3%
14-day change (14d)
-0.1%
30-day change
-12.3%
30-day relative strength
-17.3%
Benchmark change
+5.0%
Nearest support
459.74
Nearest resistance
556.01
Volume accumulation ratio
0.77

Trends

Evidence

Average earnings surprise
+12.9%
  • January 27, 2026: actual EPS 8.14 vs estimate 7.42 (surprise +9.7%)
  • October 24, 2025: actual EPS 6.96 vs estimate 5.73 (surprise +21.6%)
  • July 25, 2025: actual EPS 6.84 vs estimate 6.32 (surprise +8.2%)
  • April 25, 2025: actual EPS 6.45 vs estimate 5.75 (surprise +12.1%)

Expected move

There is no implied-move data available for this event.

Reactions over its last 18 earnings

Median move
4.2%
75th percentile move
5.6%
90th percentile move
9.6%
Up / down moves
7 / 11
Average up move
+4.8%
Average down move
-5.7%

Monitoring and close

What HCA Healthcare, Inc. reported

There is no monitoring data available for this event.

Pre-market second reading after the results

There is no second reading available for this event.

How the stock reacted

Consolidated
+3.1%
Max move
+3.4%

No verdict: the outlook took no direction, so there is nothing to score as a hit or a miss.